Global GLP-1 Agonist Market Growth 2025-2031
The global GLP-1 Agonist market size is predicted to grow from US$ 23000 million in 2025 to US$ 59680 million in 2031; it is expected to grow at a CAGR of 17.2% from 2025 to 2031.
GLP-1 is a polypeptide hormone secreted by the intestine after being stimulated by food. It can stimulate the pancreatic beta cells to secrete insulin and participate in the regulation of blood sugar balance in the human body. However, natural GLP-1 is easily degraded by dipeptidyl peptidase in vivo and loses its activity. In order to make GLP-1 better for clinical application, drug developers have modified its structure and developed a series of GLP-1 receptor agonists. GLP-1 receptor agonists can exert the same biological effects as natural GLP-1, and can also avoid being degraded and inactivated, thereby prolonging the action time.
United States market for GLP-1 Agonist is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for GLP-1 Agonist is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for GLP-1 Agonist is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key GLP-1 Agonist players cover Novo Nordisk, AstraZeneca, Sanofi, GSK, Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Agonist Industry Forecast” looks at past sales and reviews total world GLP-1 Agonist sales in 2024, providing a comprehensive analysis by region and market sector of projected GLP-1 Agonist sales for 2025 through 2031. With GLP-1 Agonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Agonist industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Agonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Agonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Agonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Agonist and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Agonist.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Agonist market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global GLP-1 Agonist market?
What factors are driving GLP-1 Agonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Agonist market opportunities vary by end market size?
How does GLP-1 Agonist break out by Type, by Application?
GLP-1 is a polypeptide hormone secreted by the intestine after being stimulated by food. It can stimulate the pancreatic beta cells to secrete insulin and participate in the regulation of blood sugar balance in the human body. However, natural GLP-1 is easily degraded by dipeptidyl peptidase in vivo and loses its activity. In order to make GLP-1 better for clinical application, drug developers have modified its structure and developed a series of GLP-1 receptor agonists. GLP-1 receptor agonists can exert the same biological effects as natural GLP-1, and can also avoid being degraded and inactivated, thereby prolonging the action time.
United States market for GLP-1 Agonist is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for GLP-1 Agonist is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for GLP-1 Agonist is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key GLP-1 Agonist players cover Novo Nordisk, AstraZeneca, Sanofi, GSK, Eli Lilly, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Agonist Industry Forecast” looks at past sales and reviews total world GLP-1 Agonist sales in 2024, providing a comprehensive analysis by region and market sector of projected GLP-1 Agonist sales for 2025 through 2031. With GLP-1 Agonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Agonist industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Agonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Agonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Agonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Agonist and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Agonist.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Agonist market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Long-Acting Drug
- Short-Acting Drug
- Diabetes
- Obesity
- Nonalcoholic Fatty Liver Disease
- Metabolic Disorder
- Alzheimer's Disease
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- AstraZeneca
- Sanofi
- GSK
- Eli Lilly
- Zealand Pharma A/S
- hansoh
- BENEMAE
What is the 10-year outlook for the global GLP-1 Agonist market?
What factors are driving GLP-1 Agonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Agonist market opportunities vary by end market size?
How does GLP-1 Agonist break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Agonist Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for GLP-1 Agonist by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for GLP-1 Agonist by Country/Region, 2020, 2024 & 2031
2.2 GLP-1 Agonist Segment by Type
2.2.1 Long-Acting Drug
2.2.2 Short-Acting Drug
2.3 GLP-1 Agonist Sales by Type
2.3.1 Global GLP-1 Agonist Sales Market Share by Type (2020-2025)
2.3.2 Global GLP-1 Agonist Revenue and Market Share by Type (2020-2025)
2.3.3 Global GLP-1 Agonist Sale Price by Type (2020-2025)
2.4 GLP-1 Agonist Segment by Application
2.4.1 Diabetes
2.4.2 Obesity
2.4.3 Nonalcoholic Fatty Liver Disease
2.4.4 Metabolic Disorder
2.4.5 Alzheimer's Disease
2.4.6 Other
2.5 GLP-1 Agonist Sales by Application
2.5.1 Global GLP-1 Agonist Sale Market Share by Application (2020-2025)
2.5.2 Global GLP-1 Agonist Revenue and Market Share by Application (2020-2025)
2.5.3 Global GLP-1 Agonist Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Agonist Breakdown Data by Company
3.1.1 Global GLP-1 Agonist Annual Sales by Company (2020-2025)
3.1.2 Global GLP-1 Agonist Sales Market Share by Company (2020-2025)
3.2 Global GLP-1 Agonist Annual Revenue by Company (2020-2025)
3.2.1 Global GLP-1 Agonist Revenue by Company (2020-2025)
3.2.2 Global GLP-1 Agonist Revenue Market Share by Company (2020-2025)
3.3 Global GLP-1 Agonist Sale Price by Company
3.4 Key Manufacturers GLP-1 Agonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Agonist Product Location Distribution
3.4.2 Players GLP-1 Agonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 AGONIST BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Agonist Market Size by Geographic Region (2020-2025)
4.1.1 Global GLP-1 Agonist Annual Sales by Geographic Region (2020-2025)
4.1.2 Global GLP-1 Agonist Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic GLP-1 Agonist Market Size by Country/Region (2020-2025)
4.2.1 Global GLP-1 Agonist Annual Sales by Country/Region (2020-2025)
4.2.2 Global GLP-1 Agonist Annual Revenue by Country/Region (2020-2025)
4.3 Americas GLP-1 Agonist Sales Growth
4.4 APAC GLP-1 Agonist Sales Growth
4.5 Europe GLP-1 Agonist Sales Growth
4.6 Middle East & Africa GLP-1 Agonist Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Agonist Sales by Country
5.1.1 Americas GLP-1 Agonist Sales by Country (2020-2025)
5.1.2 Americas GLP-1 Agonist Revenue by Country (2020-2025)
5.2 Americas GLP-1 Agonist Sales by Type (2020-2025)
5.3 Americas GLP-1 Agonist Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Agonist Sales by Region
6.1.1 APAC GLP-1 Agonist Sales by Region (2020-2025)
6.1.2 APAC GLP-1 Agonist Revenue by Region (2020-2025)
6.2 APAC GLP-1 Agonist Sales by Type (2020-2025)
6.3 APAC GLP-1 Agonist Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Agonist by Country
7.1.1 Europe GLP-1 Agonist Sales by Country (2020-2025)
7.1.2 Europe GLP-1 Agonist Revenue by Country (2020-2025)
7.2 Europe GLP-1 Agonist Sales by Type (2020-2025)
7.3 Europe GLP-1 Agonist Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Agonist by Country
8.1.1 Middle East & Africa GLP-1 Agonist Sales by Country (2020-2025)
8.1.2 Middle East & Africa GLP-1 Agonist Revenue by Country (2020-2025)
8.2 Middle East & Africa GLP-1 Agonist Sales by Type (2020-2025)
8.3 Middle East & Africa GLP-1 Agonist Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Agonist
10.3 Manufacturing Process Analysis of GLP-1 Agonist
10.4 Industry Chain Structure of GLP-1 Agonist
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Agonist Distributors
11.3 GLP-1 Agonist Customer
12 WORLD FORECAST REVIEW FOR GLP-1 AGONIST BY GEOGRAPHIC REGION
12.1 Global GLP-1 Agonist Market Size Forecast by Region
12.1.1 Global GLP-1 Agonist Forecast by Region (2026-2031)
12.1.2 Global GLP-1 Agonist Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global GLP-1 Agonist Forecast by Type (2026-2031)
12.7 Global GLP-1 Agonist Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Agonist Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 Agonist Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi GLP-1 Agonist Product Portfolios and Specifications
13.3.3 Sanofi GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK GLP-1 Agonist Product Portfolios and Specifications
13.4.3 GSK GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly GLP-1 Agonist Product Portfolios and Specifications
13.5.3 Eli Lilly GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Zealand Pharma A/S
13.6.1 Zealand Pharma A/S Company Information
13.6.2 Zealand Pharma A/S GLP-1 Agonist Product Portfolios and Specifications
13.6.3 Zealand Pharma A/S GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Zealand Pharma A/S Main Business Overview
13.6.5 Zealand Pharma A/S Latest Developments
13.7 hansoh
13.7.1 hansoh Company Information
13.7.2 hansoh GLP-1 Agonist Product Portfolios and Specifications
13.7.3 hansoh GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 hansoh Main Business Overview
13.7.5 hansoh Latest Developments
13.8 BENEMAE
13.8.1 BENEMAE Company Information
13.8.2 BENEMAE GLP-1 Agonist Product Portfolios and Specifications
13.8.3 BENEMAE GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 BENEMAE Main Business Overview
13.8.5 BENEMAE Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Agonist Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for GLP-1 Agonist by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for GLP-1 Agonist by Country/Region, 2020, 2024 & 2031
2.2 GLP-1 Agonist Segment by Type
2.2.1 Long-Acting Drug
2.2.2 Short-Acting Drug
2.3 GLP-1 Agonist Sales by Type
2.3.1 Global GLP-1 Agonist Sales Market Share by Type (2020-2025)
2.3.2 Global GLP-1 Agonist Revenue and Market Share by Type (2020-2025)
2.3.3 Global GLP-1 Agonist Sale Price by Type (2020-2025)
2.4 GLP-1 Agonist Segment by Application
2.4.1 Diabetes
2.4.2 Obesity
2.4.3 Nonalcoholic Fatty Liver Disease
2.4.4 Metabolic Disorder
2.4.5 Alzheimer's Disease
2.4.6 Other
2.5 GLP-1 Agonist Sales by Application
2.5.1 Global GLP-1 Agonist Sale Market Share by Application (2020-2025)
2.5.2 Global GLP-1 Agonist Revenue and Market Share by Application (2020-2025)
2.5.3 Global GLP-1 Agonist Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Agonist Breakdown Data by Company
3.1.1 Global GLP-1 Agonist Annual Sales by Company (2020-2025)
3.1.2 Global GLP-1 Agonist Sales Market Share by Company (2020-2025)
3.2 Global GLP-1 Agonist Annual Revenue by Company (2020-2025)
3.2.1 Global GLP-1 Agonist Revenue by Company (2020-2025)
3.2.2 Global GLP-1 Agonist Revenue Market Share by Company (2020-2025)
3.3 Global GLP-1 Agonist Sale Price by Company
3.4 Key Manufacturers GLP-1 Agonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Agonist Product Location Distribution
3.4.2 Players GLP-1 Agonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 AGONIST BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Agonist Market Size by Geographic Region (2020-2025)
4.1.1 Global GLP-1 Agonist Annual Sales by Geographic Region (2020-2025)
4.1.2 Global GLP-1 Agonist Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic GLP-1 Agonist Market Size by Country/Region (2020-2025)
4.2.1 Global GLP-1 Agonist Annual Sales by Country/Region (2020-2025)
4.2.2 Global GLP-1 Agonist Annual Revenue by Country/Region (2020-2025)
4.3 Americas GLP-1 Agonist Sales Growth
4.4 APAC GLP-1 Agonist Sales Growth
4.5 Europe GLP-1 Agonist Sales Growth
4.6 Middle East & Africa GLP-1 Agonist Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Agonist Sales by Country
5.1.1 Americas GLP-1 Agonist Sales by Country (2020-2025)
5.1.2 Americas GLP-1 Agonist Revenue by Country (2020-2025)
5.2 Americas GLP-1 Agonist Sales by Type (2020-2025)
5.3 Americas GLP-1 Agonist Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Agonist Sales by Region
6.1.1 APAC GLP-1 Agonist Sales by Region (2020-2025)
6.1.2 APAC GLP-1 Agonist Revenue by Region (2020-2025)
6.2 APAC GLP-1 Agonist Sales by Type (2020-2025)
6.3 APAC GLP-1 Agonist Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Agonist by Country
7.1.1 Europe GLP-1 Agonist Sales by Country (2020-2025)
7.1.2 Europe GLP-1 Agonist Revenue by Country (2020-2025)
7.2 Europe GLP-1 Agonist Sales by Type (2020-2025)
7.3 Europe GLP-1 Agonist Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Agonist by Country
8.1.1 Middle East & Africa GLP-1 Agonist Sales by Country (2020-2025)
8.1.2 Middle East & Africa GLP-1 Agonist Revenue by Country (2020-2025)
8.2 Middle East & Africa GLP-1 Agonist Sales by Type (2020-2025)
8.3 Middle East & Africa GLP-1 Agonist Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Agonist
10.3 Manufacturing Process Analysis of GLP-1 Agonist
10.4 Industry Chain Structure of GLP-1 Agonist
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Agonist Distributors
11.3 GLP-1 Agonist Customer
12 WORLD FORECAST REVIEW FOR GLP-1 AGONIST BY GEOGRAPHIC REGION
12.1 Global GLP-1 Agonist Market Size Forecast by Region
12.1.1 Global GLP-1 Agonist Forecast by Region (2026-2031)
12.1.2 Global GLP-1 Agonist Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global GLP-1 Agonist Forecast by Type (2026-2031)
12.7 Global GLP-1 Agonist Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Agonist Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 Agonist Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi GLP-1 Agonist Product Portfolios and Specifications
13.3.3 Sanofi GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK GLP-1 Agonist Product Portfolios and Specifications
13.4.3 GSK GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly GLP-1 Agonist Product Portfolios and Specifications
13.5.3 Eli Lilly GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Zealand Pharma A/S
13.6.1 Zealand Pharma A/S Company Information
13.6.2 Zealand Pharma A/S GLP-1 Agonist Product Portfolios and Specifications
13.6.3 Zealand Pharma A/S GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Zealand Pharma A/S Main Business Overview
13.6.5 Zealand Pharma A/S Latest Developments
13.7 hansoh
13.7.1 hansoh Company Information
13.7.2 hansoh GLP-1 Agonist Product Portfolios and Specifications
13.7.3 hansoh GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 hansoh Main Business Overview
13.7.5 hansoh Latest Developments
13.8 BENEMAE
13.8.1 BENEMAE Company Information
13.8.2 BENEMAE GLP-1 Agonist Product Portfolios and Specifications
13.8.3 BENEMAE GLP-1 Agonist Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 BENEMAE Main Business Overview
13.8.5 BENEMAE Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 Agonist Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. GLP-1 Agonist Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Long-Acting Drug
Table 4. Major Players of Short-Acting Drug
Table 5. Global GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 6. Global GLP-1 Agonist Sales Market Share by Type (2020-2025)
Table 7. Global GLP-1 Agonist Revenue by Type (2020-2025) & ($ million)
Table 8. Global GLP-1 Agonist Revenue Market Share by Type (2020-2025)
Table 9. Global GLP-1 Agonist Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global GLP-1 Agonist Sale by Application (2020-2025) & (K Units)
Table 11. Global GLP-1 Agonist Sale Market Share by Application (2020-2025)
Table 12. Global GLP-1 Agonist Revenue by Application (2020-2025) & ($ million)
Table 13. Global GLP-1 Agonist Revenue Market Share by Application (2020-2025)
Table 14. Global GLP-1 Agonist Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global GLP-1 Agonist Sales by Company (2020-2025) & (K Units)
Table 16. Global GLP-1 Agonist Sales Market Share by Company (2020-2025)
Table 17. Global GLP-1 Agonist Revenue by Company (2020-2025) & ($ millions)
Table 18. Global GLP-1 Agonist Revenue Market Share by Company (2020-2025)
Table 19. Global GLP-1 Agonist Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 Agonist Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Agonist Products Offered
Table 22. GLP-1 Agonist Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Agonist Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global GLP-1 Agonist Sales Market Share Geographic Region (2020-2025)
Table 27. Global GLP-1 Agonist Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global GLP-1 Agonist Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global GLP-1 Agonist Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global GLP-1 Agonist Sales Market Share by Country/Region (2020-2025)
Table 31. Global GLP-1 Agonist Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global GLP-1 Agonist Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas GLP-1 Agonist Sales by Country (2020-2025) & (K Units)
Table 34. Americas GLP-1 Agonist Sales Market Share by Country (2020-2025)
Table 35. Americas GLP-1 Agonist Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 37. Americas GLP-1 Agonist Sales by Application (2020-2025) & (K Units)
Table 38. APAC GLP-1 Agonist Sales by Region (2020-2025) & (K Units)
Table 39. APAC GLP-1 Agonist Sales Market Share by Region (2020-2025)
Table 40. APAC GLP-1 Agonist Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 42. APAC GLP-1 Agonist Sales by Application (2020-2025) & (K Units)
Table 43. Europe GLP-1 Agonist Sales by Country (2020-2025) & (K Units)
Table 44. Europe GLP-1 Agonist Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 46. Europe GLP-1 Agonist Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa GLP-1 Agonist Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa GLP-1 Agonist Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa GLP-1 Agonist Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Agonist
Table 52. Key Market Challenges & Risks of GLP-1 Agonist
Table 53. Key Industry Trends of GLP-1 Agonist
Table 54. GLP-1 Agonist Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Agonist Distributors List
Table 57. GLP-1 Agonist Customer List
Table 58. Global GLP-1 Agonist Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global GLP-1 Agonist Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas GLP-1 Agonist Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas GLP-1 Agonist Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC GLP-1 Agonist Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC GLP-1 Agonist Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe GLP-1 Agonist Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe GLP-1 Agonist Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa GLP-1 Agonist Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa GLP-1 Agonist Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global GLP-1 Agonist Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global GLP-1 Agonist Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global GLP-1 Agonist Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global GLP-1 Agonist Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Agonist Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. AstraZeneca Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca GLP-1 Agonist Product Portfolios and Specifications
Table 79. AstraZeneca GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Sanofi Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi GLP-1 Agonist Product Portfolios and Specifications
Table 84. Sanofi GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. GSK Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK GLP-1 Agonist Product Portfolios and Specifications
Table 89. GSK GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Eli Lilly Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly GLP-1 Agonist Product Portfolios and Specifications
Table 94. Eli Lilly GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Eli Lilly Main Business
Table 96. Eli Lilly Latest Developments
Table 97. Zealand Pharma A/S Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 98. Zealand Pharma A/S GLP-1 Agonist Product Portfolios and Specifications
Table 99. Zealand Pharma A/S GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Zealand Pharma A/S Main Business
Table 101. Zealand Pharma A/S Latest Developments
Table 102. hansoh Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 103. hansoh GLP-1 Agonist Product Portfolios and Specifications
Table 104. hansoh GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. hansoh Main Business
Table 106. hansoh Latest Developments
Table 107. BENEMAE Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 108. BENEMAE GLP-1 Agonist Product Portfolios and Specifications
Table 109. BENEMAE GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. BENEMAE Main Business
Table 111. BENEMAE Latest Developments
Table 1. GLP-1 Agonist Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. GLP-1 Agonist Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Long-Acting Drug
Table 4. Major Players of Short-Acting Drug
Table 5. Global GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 6. Global GLP-1 Agonist Sales Market Share by Type (2020-2025)
Table 7. Global GLP-1 Agonist Revenue by Type (2020-2025) & ($ million)
Table 8. Global GLP-1 Agonist Revenue Market Share by Type (2020-2025)
Table 9. Global GLP-1 Agonist Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global GLP-1 Agonist Sale by Application (2020-2025) & (K Units)
Table 11. Global GLP-1 Agonist Sale Market Share by Application (2020-2025)
Table 12. Global GLP-1 Agonist Revenue by Application (2020-2025) & ($ million)
Table 13. Global GLP-1 Agonist Revenue Market Share by Application (2020-2025)
Table 14. Global GLP-1 Agonist Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global GLP-1 Agonist Sales by Company (2020-2025) & (K Units)
Table 16. Global GLP-1 Agonist Sales Market Share by Company (2020-2025)
Table 17. Global GLP-1 Agonist Revenue by Company (2020-2025) & ($ millions)
Table 18. Global GLP-1 Agonist Revenue Market Share by Company (2020-2025)
Table 19. Global GLP-1 Agonist Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 Agonist Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Agonist Products Offered
Table 22. GLP-1 Agonist Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Agonist Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global GLP-1 Agonist Sales Market Share Geographic Region (2020-2025)
Table 27. Global GLP-1 Agonist Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global GLP-1 Agonist Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global GLP-1 Agonist Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global GLP-1 Agonist Sales Market Share by Country/Region (2020-2025)
Table 31. Global GLP-1 Agonist Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global GLP-1 Agonist Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas GLP-1 Agonist Sales by Country (2020-2025) & (K Units)
Table 34. Americas GLP-1 Agonist Sales Market Share by Country (2020-2025)
Table 35. Americas GLP-1 Agonist Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 37. Americas GLP-1 Agonist Sales by Application (2020-2025) & (K Units)
Table 38. APAC GLP-1 Agonist Sales by Region (2020-2025) & (K Units)
Table 39. APAC GLP-1 Agonist Sales Market Share by Region (2020-2025)
Table 40. APAC GLP-1 Agonist Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 42. APAC GLP-1 Agonist Sales by Application (2020-2025) & (K Units)
Table 43. Europe GLP-1 Agonist Sales by Country (2020-2025) & (K Units)
Table 44. Europe GLP-1 Agonist Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 46. Europe GLP-1 Agonist Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa GLP-1 Agonist Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa GLP-1 Agonist Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa GLP-1 Agonist Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa GLP-1 Agonist Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Agonist
Table 52. Key Market Challenges & Risks of GLP-1 Agonist
Table 53. Key Industry Trends of GLP-1 Agonist
Table 54. GLP-1 Agonist Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Agonist Distributors List
Table 57. GLP-1 Agonist Customer List
Table 58. Global GLP-1 Agonist Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global GLP-1 Agonist Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas GLP-1 Agonist Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas GLP-1 Agonist Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC GLP-1 Agonist Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC GLP-1 Agonist Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe GLP-1 Agonist Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe GLP-1 Agonist Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa GLP-1 Agonist Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa GLP-1 Agonist Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global GLP-1 Agonist Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global GLP-1 Agonist Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global GLP-1 Agonist Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global GLP-1 Agonist Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Agonist Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. AstraZeneca Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca GLP-1 Agonist Product Portfolios and Specifications
Table 79. AstraZeneca GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Sanofi Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi GLP-1 Agonist Product Portfolios and Specifications
Table 84. Sanofi GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. GSK Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK GLP-1 Agonist Product Portfolios and Specifications
Table 89. GSK GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Eli Lilly Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly GLP-1 Agonist Product Portfolios and Specifications
Table 94. Eli Lilly GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Eli Lilly Main Business
Table 96. Eli Lilly Latest Developments
Table 97. Zealand Pharma A/S Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 98. Zealand Pharma A/S GLP-1 Agonist Product Portfolios and Specifications
Table 99. Zealand Pharma A/S GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Zealand Pharma A/S Main Business
Table 101. Zealand Pharma A/S Latest Developments
Table 102. hansoh Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 103. hansoh GLP-1 Agonist Product Portfolios and Specifications
Table 104. hansoh GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. hansoh Main Business
Table 106. hansoh Latest Developments
Table 107. BENEMAE Basic Information, GLP-1 Agonist Manufacturing Base, Sales Area and Its Competitors
Table 108. BENEMAE GLP-1 Agonist Product Portfolios and Specifications
Table 109. BENEMAE GLP-1 Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. BENEMAE Main Business
Table 111. BENEMAE Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1 Agonist
Figure 2. GLP-1 Agonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Agonist Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global GLP-1 Agonist Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. GLP-1 Agonist Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. GLP-1 Agonist Sales Market Share by Country/Region (2024)
Figure 10. GLP-1 Agonist Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Long-Acting Drug
Figure 12. Product Picture of Short-Acting Drug
Figure 13. Global GLP-1 Agonist Sales Market Share by Type in 2025
Figure 14. Global GLP-1 Agonist Revenue Market Share by Type (2020-2025)
Figure 15. GLP-1 Agonist Consumed in Diabetes
Figure 16. Global GLP-1 Agonist Market: Diabetes (2020-2025) & (K Units)
Figure 17. GLP-1 Agonist Consumed in Obesity
Figure 18. Global GLP-1 Agonist Market: Obesity (2020-2025) & (K Units)
Figure 19. GLP-1 Agonist Consumed in Nonalcoholic Fatty Liver Disease
Figure 20. Global GLP-1 Agonist Market: Nonalcoholic Fatty Liver Disease (2020-2025) & (K Units)
Figure 21. GLP-1 Agonist Consumed in Metabolic Disorder
Figure 22. Global GLP-1 Agonist Market: Metabolic Disorder (2020-2025) & (K Units)
Figure 23. GLP-1 Agonist Consumed in Alzheimer's Disease
Figure 24. Global GLP-1 Agonist Market: Alzheimer's Disease (2020-2025) & (K Units)
Figure 25. GLP-1 Agonist Consumed in Other
Figure 26. Global GLP-1 Agonist Market: Other (2020-2025) & (K Units)
Figure 27. Global GLP-1 Agonist Sale Market Share by Application (2024)
Figure 28. Global GLP-1 Agonist Revenue Market Share by Application in 2025
Figure 29. GLP-1 Agonist Sales by Company in 2025 (K Units)
Figure 30. Global GLP-1 Agonist Sales Market Share by Company in 2025
Figure 31. GLP-1 Agonist Revenue by Company in 2025 ($ millions)
Figure 32. Global GLP-1 Agonist Revenue Market Share by Company in 2025
Figure 33. Global GLP-1 Agonist Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global GLP-1 Agonist Revenue Market Share by Geographic Region in 2025
Figure 35. Americas GLP-1 Agonist Sales 2020-2025 (K Units)
Figure 36. Americas GLP-1 Agonist Revenue 2020-2025 ($ millions)
Figure 37. APAC GLP-1 Agonist Sales 2020-2025 (K Units)
Figure 38. APAC GLP-1 Agonist Revenue 2020-2025 ($ millions)
Figure 39. Europe GLP-1 Agonist Sales 2020-2025 (K Units)
Figure 40. Europe GLP-1 Agonist Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa GLP-1 Agonist Sales 2020-2025 (K Units)
Figure 42. Middle East & Africa GLP-1 Agonist Revenue 2020-2025 ($ millions)
Figure 43. Americas GLP-1 Agonist Sales Market Share by Country in 2025
Figure 44. Americas GLP-1 Agonist Revenue Market Share by Country (2020-2025)
Figure 45. Americas GLP-1 Agonist Sales Market Share by Type (2020-2025)
Figure 46. Americas GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 47. United States GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC GLP-1 Agonist Sales Market Share by Region in 2025
Figure 52. APAC GLP-1 Agonist Revenue Market Share by Region (2020-2025)
Figure 53. APAC GLP-1 Agonist Sales Market Share by Type (2020-2025)
Figure 54. APAC GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 55. China GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 59. India GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe GLP-1 Agonist Sales Market Share by Country in 2025
Figure 63. Europe GLP-1 Agonist Revenue Market Share by Country (2020-2025)
Figure 64. Europe GLP-1 Agonist Sales Market Share by Type (2020-2025)
Figure 65. Europe GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 66. Germany GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 67. France GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 68. UK GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa GLP-1 Agonist Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa GLP-1 Agonist Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 74. Egypt GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of GLP-1 Agonist in 2025
Figure 80. Manufacturing Process Analysis of GLP-1 Agonist
Figure 81. Industry Chain Structure of GLP-1 Agonist
Figure 82. Channels of Distribution
Figure 83. Global GLP-1 Agonist Sales Market Forecast by Region (2026-2031)
Figure 84. Global GLP-1 Agonist Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global GLP-1 Agonist Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global GLP-1 Agonist Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global GLP-1 Agonist Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global GLP-1 Agonist Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of GLP-1 Agonist
Figure 2. GLP-1 Agonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Agonist Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global GLP-1 Agonist Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. GLP-1 Agonist Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. GLP-1 Agonist Sales Market Share by Country/Region (2024)
Figure 10. GLP-1 Agonist Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Long-Acting Drug
Figure 12. Product Picture of Short-Acting Drug
Figure 13. Global GLP-1 Agonist Sales Market Share by Type in 2025
Figure 14. Global GLP-1 Agonist Revenue Market Share by Type (2020-2025)
Figure 15. GLP-1 Agonist Consumed in Diabetes
Figure 16. Global GLP-1 Agonist Market: Diabetes (2020-2025) & (K Units)
Figure 17. GLP-1 Agonist Consumed in Obesity
Figure 18. Global GLP-1 Agonist Market: Obesity (2020-2025) & (K Units)
Figure 19. GLP-1 Agonist Consumed in Nonalcoholic Fatty Liver Disease
Figure 20. Global GLP-1 Agonist Market: Nonalcoholic Fatty Liver Disease (2020-2025) & (K Units)
Figure 21. GLP-1 Agonist Consumed in Metabolic Disorder
Figure 22. Global GLP-1 Agonist Market: Metabolic Disorder (2020-2025) & (K Units)
Figure 23. GLP-1 Agonist Consumed in Alzheimer's Disease
Figure 24. Global GLP-1 Agonist Market: Alzheimer's Disease (2020-2025) & (K Units)
Figure 25. GLP-1 Agonist Consumed in Other
Figure 26. Global GLP-1 Agonist Market: Other (2020-2025) & (K Units)
Figure 27. Global GLP-1 Agonist Sale Market Share by Application (2024)
Figure 28. Global GLP-1 Agonist Revenue Market Share by Application in 2025
Figure 29. GLP-1 Agonist Sales by Company in 2025 (K Units)
Figure 30. Global GLP-1 Agonist Sales Market Share by Company in 2025
Figure 31. GLP-1 Agonist Revenue by Company in 2025 ($ millions)
Figure 32. Global GLP-1 Agonist Revenue Market Share by Company in 2025
Figure 33. Global GLP-1 Agonist Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global GLP-1 Agonist Revenue Market Share by Geographic Region in 2025
Figure 35. Americas GLP-1 Agonist Sales 2020-2025 (K Units)
Figure 36. Americas GLP-1 Agonist Revenue 2020-2025 ($ millions)
Figure 37. APAC GLP-1 Agonist Sales 2020-2025 (K Units)
Figure 38. APAC GLP-1 Agonist Revenue 2020-2025 ($ millions)
Figure 39. Europe GLP-1 Agonist Sales 2020-2025 (K Units)
Figure 40. Europe GLP-1 Agonist Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa GLP-1 Agonist Sales 2020-2025 (K Units)
Figure 42. Middle East & Africa GLP-1 Agonist Revenue 2020-2025 ($ millions)
Figure 43. Americas GLP-1 Agonist Sales Market Share by Country in 2025
Figure 44. Americas GLP-1 Agonist Revenue Market Share by Country (2020-2025)
Figure 45. Americas GLP-1 Agonist Sales Market Share by Type (2020-2025)
Figure 46. Americas GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 47. United States GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC GLP-1 Agonist Sales Market Share by Region in 2025
Figure 52. APAC GLP-1 Agonist Revenue Market Share by Region (2020-2025)
Figure 53. APAC GLP-1 Agonist Sales Market Share by Type (2020-2025)
Figure 54. APAC GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 55. China GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 59. India GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe GLP-1 Agonist Sales Market Share by Country in 2025
Figure 63. Europe GLP-1 Agonist Revenue Market Share by Country (2020-2025)
Figure 64. Europe GLP-1 Agonist Sales Market Share by Type (2020-2025)
Figure 65. Europe GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 66. Germany GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 67. France GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 68. UK GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa GLP-1 Agonist Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa GLP-1 Agonist Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 74. Egypt GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries GLP-1 Agonist Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of GLP-1 Agonist in 2025
Figure 80. Manufacturing Process Analysis of GLP-1 Agonist
Figure 81. Industry Chain Structure of GLP-1 Agonist
Figure 82. Channels of Distribution
Figure 83. Global GLP-1 Agonist Sales Market Forecast by Region (2026-2031)
Figure 84. Global GLP-1 Agonist Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global GLP-1 Agonist Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global GLP-1 Agonist Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global GLP-1 Agonist Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global GLP-1 Agonist Revenue Market Share Forecast by Application (2026-2031)
